Retrons adapted from E. coli enable genome editing in 15 diverse bacterial species, expanding recombineering tools across major microbial phyla.

Sun Pharmaceutical Industries has agreed to acquire Organon for $11.75 billion in a deal intended to catapult the buyer into ...

Senescent cells walk a tightrope, risking cell death with high levels of iron and other damaging agents, but compensating for this by overproducing a protective protein, GPX4, which staves off death.

The researchers want to better understand the fundamental physics of the pencil beam and the mechanisms behind its self ...

Using various imaging techniques, the scientists tied abdominal movements to shifts in mouse brains and the movement of ...

Stocks of most publicly traded psychedelic drug developers jumped soon after President Donald Trump signed Executive Order ...

The results of a study by researchers at the International Centre for Genetic Engineering and Biotechnology (ICGEB) suggest ...

A cellular-resolution map of prenatal brain development in Down syndrome reveals disrupted neuron production timing and altered cell types.

This week's episode includes an update from AACR, HIV CRISPR screen mapping, tissue engineering in the liver, and cancer business news.

Investigational ADC QLS5132 showed promising clinical benefit and manageable safety in Phase I trial patients with platinum-resistant ovarian cancer.

By analyzing CpG-based DNA methylation, the model achieved 87% accuracy when applied to 31 cases representing 17 different cancer types.

At AACR, first‑in‑human KIR‑CAR T data show early activity in solid tumors and introduce a novel design aimed at limiting T ...